Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$67.4M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$56.4M |
| 3 |
Ameren
AEE
|
+$42.8M |
| 4 |
Vistra
VST
|
+$42M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$40.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$62.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$45.2M |
| 3 |
Energy Transfer Partners
ET
|
+$40.5M |
| 4 |
ConocoPhillips
COP
|
+$38M |
| 5 |
PPLI
People Inc
PPLI
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Financials | 16.46% |
| 3 | Consumer Discretionary | 14.52% |
| 4 | Healthcare | 11.2% |
| 5 | Industrials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Stanley Black & Decker
SWK
$14.9B
| $1.34M | 0.03% |
8,100
+200
| +3% | +$31K |
|
427
Cognizant
CTSH
$28B
| $1.34M | 0.03% |
21,550
-8,283
| -28% | -$512K |
|
|
XLNX
428
DELISTED
Xilinx Inc
XLNX
| $1.34M | 0.03% |
13,670
+11,370
| +494% | +$1.07M |
|
429
New Jersey Resources
NJR
$5.45B
| $1.33M | 0.03% |
29,922
+17,490
| +141% | +$756K |
|
430
IMAX
IMAX
$3B
| $1.33M | 0.03% |
+65,100
| New | +$1.39M |
|
|
BLUE
431
DELISTED
bluebird bio
BLUE
| $1.33M | 0.03% |
+1,166
| New | +$1.27M |
|
432
AptarGroup
ATR
$8.57B
| $1.32M | 0.03% |
+11,418
| New | +$1.3M |
|
433
RTX Corp
RTX
$282B
| $1.3M | 0.03% |
13,824
-23,518
| -63% | -$2.13M |
|
|
AAMI
434
Acadian Asset Management
AAMI
$3.26B
| $1.3M | 0.03% |
127,437
-438,877
| -77% | -$4.28M |
|
435
Albemarle
ALB
$16.7B
| $1.3M | 0.03% |
17,802
+7,702
| +76% | +$514K |
|
436
LKQ Corp
LKQ
$6.51B
| $1.3M | 0.03% |
36,413
-162,587
| -82% | -$5.52M |
|
437
H&R Block
HRB
$6.62B
| $1.3M | 0.03% |
+55,234
| New | +$1.33M |
|
438
Wabtec
WAB
$50.3B
| $1.3M | 0.03% |
+16,664
| New | +$1.23M |
|
439
Realty Income
O
$59.8B
| $1.29M | 0.03% |
+18,062
| New | +$1.35M |
|
440
Sempra
SRE
$55.3B
| $1.29M | 0.03% |
17,000
-5,088
| -23% | -$373K |
|
441
Colgate-Palmolive
CL
$73.8B
| $1.28M | 0.03% |
+18,600
| New | +$1.27M |
|
442
Cummins
CMI
$78.7B
| $1.27M | 0.03% |
+7,111
| New | +$1.25M |
|
443
Criteo S.A.
CRTO
$837M
| $1.27M | 0.03% |
+73,436
| New | +$1.31M |
|
444
DexCom
DXCM
$34.4B
| $1.27M | 0.03% |
23,264
-82,340
| -78% | -$3.91M |
|
445
General Dynamics
GD
$104B
| $1.27M | 0.03% |
7,200
-1,925
| -21% | -$346K |
|
446
Brunswick
BC
$5.26B
| $1.26M | 0.03% |
+21,085
| New | +$1.22M |
|
|
APLS
447
DELISTED
Apellis Pharmaceuticals
APLS
| $1.26M | 0.03% |
+41,067
| New | +$1.14M |
|
448
Altria Group
MO
$114B
| $1.25M | 0.03% |
25,100
-74,276
| -75% | -$3.5M |
|
|
CGC
449
Canopy Growth
CGC
$472M
| $1.25M | 0.03% |
+5,940
| New | +$1.18M |
|
|
JCP
450
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.25M | 0.03% |
1,117,673
-1,218,427
| -52% | -$1.29M |
|
Similar funds
Steve Schonfeld's Q4 2019 Portfolio in Review
As of Q4 2019, Steve Schonfeld held 1,585 positions worth $4.1B, up 20% from $3.41B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $700M of net new capital in Q4 2019, opening 595 new positions and adding to 325 existing holdings. Its largest new stake was Uber: 1,194,830 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was NRG Energy, an estimated $62.3M trimmed.
- Steve Schonfeld's largest Q4 2019 buy was Uber: 1,194,830 shares worth $35.5M.
- Steve Schonfeld added most to Dominion Energy in Q4 2019, an estimated $67.4M increase.
- Steve Schonfeld's biggest Q4 2019 reduction was NRG Energy, cutting an estimated $62.3M.
- Steve Schonfeld fully exited Celgene Corp in Q4 2019, selling an estimated $45.2M.
- Steve Schonfeld's ten largest holdings make up 15% of its $4.1B portfolio in Q4 2019.
- Steve Schonfeld opened 595 new positions and closed 323 in Q4 2019.
- Steve Schonfeld's portfolio value rose 20% quarter-over-quarter to $4.1B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.